Source materials suspected in Enila contrast agent probe
This article was originally published in Clinica
Executive Summary
Initial investigations into Brazilian firm Enila, whose Celobar contrast agent is being directly linked to a rising number of deaths, have raised questions surrounding the origin of a significant amount of the agent's active ingredient. Separate tests on the affected lot have revealed the presence of soluble barium salts.